Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry. 2010

Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.

A simple and rapid method with high performance liquid chromatography/tandem mass spectrometry is described for the quantitation of the kinase inhibitor sorafenib and its active metabolite sorafenib N-oxide in human plasma. A protein precipitation extraction procedure was applied to 50 μL of plasma. Chromatographic separation of the two analytes, and the internal standard [(2)H(3)(13)C]-sorafenib, was achieved on a C(18) analytical column and isocratic flow at 0.3 mL/min for 4 min. Mean within-run and between-run precision for all analytes were <6.9% and accuracy was <5.3%. Calibration curves were linear over the concentration range of 50-10,000 ng/mL for sorafenib and 10-2500 ng/mL for sorafenib N-oxide. This method allows a specific, sensitive, and reliable determination of the kinase inhibitor sorafenib and its active metabolite sorafenib N-oxide in human plasma in a single analytical run.

UI MeSH Term Description Entries
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D010671 Phenylurea Compounds Compounds that include the amino-N-phenylamide structure. Phenylcarbamides,Phenylurea Derivatives,Compounds, Phenylurea,Derivatives, Phenylurea
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077157 Sorafenib A niacinamide and phenylurea derivative that inhibits multiple intracellular and cell surface kinases thought to be involved in ANGIOGENESIS, including RAF KINASES and VEGF RECEPTORS. It is used in the treatment of advanced RENAL CELL CARCINOMA and HEPATOCELLULAR CARCINOMA, and for treatment of THYROID CARCINOMA refractory to radioactive iodine therapy. 4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate,BAY 43-9006,BAY 545-9085,BAY-545-9085,BAY-673472,Nexavar,Sorafenib N-Oxide,Sorafenib Tosylate,BAY 43 9006,BAY 439006,BAY 545 9085,BAY 5459085,BAY 673472,BAY5459085,Sorafenib N Oxide
D001557 Benzenesulfonates Organic salts and esters of benzenesulfonic acid.
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
March 2017, Yao xue xue bao = Acta pharmaceutica Sinica,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
October 2012, Analytical and bioanalytical chemistry,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
October 2020, Biomedical chromatography : BMC,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
October 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
May 2022, Journal of analytical toxicology,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
May 2001, Journal of chromatography. B, Biomedical sciences and applications,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
January 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
June 2013, Acta pharmaceutica (Zagreb, Croatia),
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
February 2022, Journal of pharmaceutical and biomedical analysis,
Lie Li, and Ming Zhao, and Fariba Navid, and Keith Pratz, and B Doug Smith, and Michelle A Rudek, and Sharyn D Baker
February 2014, Journal of pharmaceutical analysis,
Copied contents to your clipboard!